Bixiye
QP26-21 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Natiijooyinka Raadinta
Soo bandhiga 1681 - 1690 ee natiijooyinka 4229
Bixiye
QP30-21 Reference Guides for Commercial Networks and Medicare Products
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP29-21 Commercial and MHCP Pharmacy Benefit Update – Growth Hormone Notification
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 14, 2021
Bixiye
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
QP65R1-21 Update: Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
QP69-21 Update for New to Market Medical Drugs: Ciltacabtagene Autoleucel
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021